Company
Headquarters: Stockholm, Sweden
Employees: 2
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $461.52 B |
Vertex Pharmaceuticals Incorporated | $107.23 B |
Regeneron Pharmaceuticals, Inc. | $100.01 B |
CSL Limited | $94.74 B |
Marinomed Biotech AG | $73.23 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Modus Therapeutics Holding Ab, a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It is developing Sevuparin, a polysaccharide to treat patients with sepsis and septic shock. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Modus Therapeutics Holding AB has the following listings and related stock indices.
Stock: OMX: MODTX wb_incandescent